Recurrent Pregnancy Loss Package (Extended)
₹45,000.00 Original price was: ₹45,000.00.₹24,600.00Current price is: ₹24,600.00.
Comprehensive genetic, hormonal & immunological panel for recurrent pregnancy loss evaluation. Early detection & expert analysis.
About this Package:
The Recurrent Pregnancy Loss (RPL) Package – Extended is a comprehensive diagnostic panel designed to evaluate possible causes of recurrent pregnancy loss. This package combines advanced genetic, hormonal, and immunological tests to identify factors that may contribute to miscarriage. Early detection allows for targeted interventions and better pregnancy outcomes.
Why Book This Package?
Thorough assessment of genetic, immunological, and hormonal factors
Recommended for women experiencing multiple miscarriages
Expert lab processing ensures accuracy and reliability
Convenient home sample collection (where available)
Tests Included:
1. Coagulation & Thrombophilia Markers
Anti-Thrombin III activity
Free Protein S
Protein C Activity (Functional)
Factor V Leiden, MTHFR, P20210 mutations
2. Antibody & Immune Panel
Cardiolipin Antibody, IgG
Cardiolipin Antibody, IgM
Phospholipid Antibodies Panel, IgG & IgM
3. Genetic & Cytogenetic Tests
Peripheral Blood Karyotyping (Non-Neoplastic)
BCR-ABL Gene Rearrangement (P190, P210)
4. Hormonal Test
Thyroid Stimulating Hormone (TSH)
5. TORCH Complex Profile (Infection Screening)
IgG Panel: Anti Toxoplasma IgG, Herpes Simplex Virus 1+2 Ab IgG, Anti Rubella IgG, Anti CMV IgG Antibodies
IgM Panel: Anti Toxoplasma IgM, Herpes Simplex Virus 1+2 Ab IgM, Anti Rubella IgM, Anti CMV IgM
How It Works:
Book the test online or at your nearest lab.
Sample collection (blood/serum) at your convenience.
Expert lab analysis with detailed reports delivered securely.
About Medanta Lab:
Medanta Lab combines cutting-edge technology with highly trained staff to provide accurate and timely results. All tests are processed under stringent quality standards, ensuring reliability for critical health decisions.


Reviews
There are no reviews yet.